CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
2017 · Nature Genetics · 658 citations
https://doi.org/10.1038/ng.3774
Z
Zachary L. Skidmore
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
292
Papers
4.3K
Citations
28
h-index
48
i10-index
Zachary L. Skidmore is an academic researcher from James S. McDonnell Foundation. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lymphoma Diagnosis and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 28, co-authored 249 publications.
ORCID: 0000-0003-1928-7139Papers by this author
worksNeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer
2017 · Clinical Cancer Research · 359 citations
https://doi.org/10.1158/1078-0432.ccr-16-3206
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
2018 · Nature Communications · 168 citations
https://doi.org/10.1038/s41467-018-06162-9
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer
2023 · Nature Communications · 123 citations
https://doi.org/10.1038/s41467-023-37266-6
A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation
2019 · Cell Reports · 32 citations
https://doi.org/10.1016/j.celrep.2019.06.098
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas
2016 · Cell Reports · 28 citations
https://doi.org/10.1016/j.celrep.2016.08.076
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat